Acute Porphyria Drug Database

B02AA02 - Tranexamic Acid
Not porphyrinogenic
NP

Rationale
Aminoacid. No CYP-interactions.
Chemical description
Amino acid plasmin inhibitor administered as tablets or infusion in situations with fibrinolysis or risk for fibrinolytic bleeding. Metabolized by acetylation and deamination
IPNet drug reports
Uneventful use reported in 4 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes B02A / B02AA or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙